» Articles » PMID: 35879516

Innovations in Ventricular Tachycardia Ablation

Overview
Publisher Springer
Date 2022 Jul 25
PMID 35879516
Authors
Affiliations
Soon will be listed here.
Abstract

Catheter ablation of ventricular arrhythmias (VAs) has evolved significantly over the past decade and is currently a well-established therapeutic option. Technological advances and improved understanding of VA mechanisms have led to tremendous innovations in VA ablation. The purpose of this review article is to provide an overview of current innovations in VA ablation. Mapping techniques, such as ultra-high density mapping, isochronal late activation mapping, and ripple mapping, have provided improved arrhythmogenic substrate delineation and potential procedural success while limiting duration of ablation procedure and potential hemodynamic compromise. Besides, more advanced mapping and ablation techniques such as epicardial and intramyocardial ablation approaches have allowed operators to more precisely target arrhythmogenic substrate. Moreover, advances in alternate energy sources, such as electroporation, as well as stereotactic radiation therapy have been proposed to be effective and safe. New catheters, such as the lattice and the saline-enhanced radiofrequency catheters, have been designed to provide deeper and more durable tissue ablation lesions compared to conventional catheters. Contact force optimization and baseline impedance modulation are important tools to optimize VT radiofrequency ablation and improve procedural success. Furthermore, advances in cardiac imaging, specifically cardiac MRI, have great potential in identifying arrhythmogenic substrate and evaluating ablation success. Overall, VA ablation has undergone significant advances over the past years. Innovations in VA mapping techniques, alternate energy source, new catheters, and utilization of cardiac imaging have great potential to improve overall procedural safety, hemodynamic stability, and procedural success.

Citing Articles

Zero-fluoroscopy approach for radiofrequency catheter ablation of left-sided, idiopathic ventricular arrhythmias - feasibility, efficacy, and safety evaluation.

Rodkiewicz D, Momot K, Kozluk E, Piatkowska A, Kwasiborski P, Buksinska-Lisik M Postepy Kardiol Interwencyjnej. 2025; 20(4):474-479.

PMID: 39897020 PMC: 11783260. DOI: 10.5114/aic.2024.142618.


Contemporary Trends in Pulsed Field Ablation for Cardiac Arrhythmias.

Yavin H, Prasad M, Gordon J, Aksu T, Huang H J Cardiovasc Dev Dis. 2025; 12(1).

PMID: 39852288 PMC: 11766314. DOI: 10.3390/jcdd12010010.


Optimizing ventricular tachycardia ablation through imaging-based assessment of arrhythmic substrate: A comprehensive review and roadmap for the future.

Burger J, Hopman L, Kemme M, Hoeksema W, Takx R, Figueras I Ventura R Heart Rhythm O2. 2024; 5(8):561-572.

PMID: 39263615 PMC: 11385403. DOI: 10.1016/j.hroo.2024.07.001.


Solving the Reach Problem: A Review of Present and Future Approaches for Addressing Ventricular Arrhythmias Arising from Deep Substrate.

Ravi V, Winterfield J, Liang J, Larsen T, Dye C, Sanders D Arrhythm Electrophysiol Rev. 2023; 12:e04.

PMID: 37600155 PMC: 10433105. DOI: 10.15420/aer.2022.28.

References
1.
Cronin E, Bogun F, Maury P, Peichl P, Chen M, Namboodiri N . 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2019; 17(1):e2-e154. PMC: 8453449. DOI: 10.1016/j.hrthm.2019.03.002. View

2.
Willems S, Tilz R, Steven D, Kaab S, Wegscheider K, Geller L . Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial. Circulation. 2020; 141(13):1057-1067. DOI: 10.1161/CIRCULATIONAHA.119.043400. View

3.
Reddy V, Reynolds M, Neuzil P, Richardson A, Taborsky M, Jongnarangsin K . Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007; 357(26):2657-65. PMC: 2390777. DOI: 10.1056/NEJMoa065457. View

4.
Sapp J, Wells G, Parkash R, Stevenson W, Blier L, Sarrazin J . Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. N Engl J Med. 2016; 375(2):111-21. DOI: 10.1056/NEJMoa1513614. View

5.
Stinnett-Donnelly J, Thompson N, Habel N, Petrov-Kondratov V, Correa de Sa D, Bates J . Effects of electrode size and spacing on the resolution of intracardiac electrograms. Coron Artery Dis. 2012; 23(2):126-32. DOI: 10.1097/MCA.0b013e3283507a9b. View